AlzeCure Pharma’s Rights Offering

Synch acted as legal advisor to AlzeCure Pharma.The board of directors for AlzeCure Pharma has resolved a rights issue of approximately SEK 53 million. In addition,the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here